SQZ Biotechnologies Co (SQZB)
0.021
0.00 (0.00%)
USD |
OTCM |
May 17, 15:23
SQZ Biotechnologies Total Assets (Quarterly): 54.15M for June 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 54.15M |
| March 31, 2023 | 73.16M |
| December 31, 2022 | 99.90M |
| September 30, 2022 | 154.85M |
| June 30, 2022 | 180.31M |
| March 31, 2022 | 200.80M |
| December 31, 2021 | 226.15M |
| Date | Value |
|---|---|
| September 30, 2021 | 244.07M |
| June 30, 2021 | 238.55M |
| March 31, 2021 | 262.87M |
| December 31, 2020 | 231.14M |
| September 30, 2020 | 176.97M |
| June 30, 2020 | 177.58M |
| December 31, 2019 | 152.35M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
54.15M
Minimum
Jun 2023
262.87M
Maximum
Mar 2021
176.63M
Average
178.94M
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 30.05M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Protalix BioTherapeutics Inc | 89.82M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 29.61M |
| Shareholders Equity (Quarterly) | 24.54M |
| Current Ratio | 2.793 |